For decades, discussions on reproductive health have largely focused on women, often overlooking the critical role men play in contraception, fertility, and family planning. However, two newly proposed bills—both titled the Contraception Begins at Erection Act—have reignited the debate on shared responsibility in reproductive health.
Board-certified physician Dr. Randall Turner highlights this imbalance, stating, “Society tends to place most of the responsibility—and even the blame—on women when it comes to birth control, pregnancy, and infertility. That needs to change.” He also points out that many men only seek reproductive health care when facing specific issues, such as infertility or sexually transmitted infections (STIs).
Barriers to Male Involvement
Despite growing recognition of the importance of male participation in reproductive health, several barriers persist. Socio-cultural norms, including traditional gender roles and patriarchal attitudes, have historically discouraged men from engaging in reproductive health services.
However, a study published in BMC Public Health reveals that this is only part of the issue. The review identifies misinformation, limited knowledge about male reproductive responsibilities, and a lack of awareness regarding the benefits of male involvement in maternity care as additional obstacles.
The Current Landscape of Male Contraception
At present, male-controlled contraceptive options remain limited to condoms and vasectomy. While condoms are widely used, their effectiveness depends on consistent and correct use. Vasectomy, on the other hand, provides a long-term solution but is often misunderstood.
A 2022 U.S. survey found that only 50.1% of men correctly understood that vasectomy does not reduce sexual desire, while 48.4% accurately recognized that it does not affect erectile function. Dr. Turner emphasizes the need for better education, stating, “Teaching boys and young men early about their role in reproductive health, expanding access to male-focused contraception options, and normalizing discussions around fertility and family planning would significantly shift the dynamic.”
Innovations in Male Contraception
Advancements in male contraceptives may soon offer new solutions. A promising development is a hormonal gel containing segesterone acetate (Nestorone) and testosterone, which suppresses sperm production more effectively than previous hormonal methods. Currently in a multicenter Phase 2b clinical trial, preliminary findings suggest it could become a viable alternative.
Meanwhile, non-hormonal options, such as occlusion gels, are also being explored. These hydrogels are injected into the vas deferens, creating a physical barrier that prevents sperm from reaching semen during ejaculation—similar to vasectomy but without surgical intervention.
Companies leading this innovation include Contraline, whose ADAM gel is in Phase 1 trials in Australia, showing no adverse effects or pregnancies over a 12-month period. NEXT Life Sciences’ Plan A aims for 2026 approval, though human testing is still in early stages.
Related topics:
Artificial Intelligence: A Game-Changer in Fertility Treatments?
EACH Chosen to Deliver Groundbreaking Virtual Women’s Health Clinic in Victoria
International Experts Call for Urgent Regulation of Assisted Reproductive Technologies (ART)
